Diversity of marine bacteria producing beta-glucosidase inhibitors by unknown
Pandey et al. Microbial Cell Factories 2013, 12:35
http://www.microbialcellfactories.com/content/12/1/35RESEARCH Open AccessDiversity of marine bacteria producing
beta-glucosidase inhibitors
Sony Pandey*, Ayinampudi Sree, Soumya Suchismita Dash, Dipti Priya Sethi and Lipsa ChowdhuryAbstract
Background: Beta-glucosidase inhibitors are being extensively studied for use as anti-diabetics, anti-obesity and
anti-tumour compounds. So far, these compounds have been reported in large numbers from plants, mushrooms,
algae and fungi. There are very few reports of such inhibitors from bacteria in the open literature, particularly
marine bacteria; although the best known inhibitor deoxynojirimycin was isolated from bacilli and actinomycete.
Through this study, we tried to discover the diversity of microbial associates of marine sponge and sediment
producing β-glucosidase inhibitors.
Results: We found 41 (22.7%) out of 181 bacteria, produced such inhibitors. The inhibitors are abundant in bacterial
associates of marine sponge Aka coralliphaga. When these bacteria were phylogenetically analyzed, it was found
that marine bacteria producing glucosidase inhibitors belong to the phylum Firmicutes (23), Actinobacteria (9),
Proteobacteria (7) and Bacteroidetes (1).
Conclusion: A significant number of marine bacteria belonging to a wide range of bacterial taxa were found to
produce β-glucosidase inhibitors. These compounds are abundantly present in bacteria of the phylum Firmicutes
followed by the phylum Actinobacteria. The results nurture a hope of finding new compounds, which can inhibit
glucosidases, in the bacterial domain of marine organisms. Thus, marine microbial cells can be utilized as producers
of pharmacologically essential enzyme inhibitors.
Keywords: Glucosidase inhibitor, Diversity, Microbial extracts, Phyla, Marine microorganisms, Anti-diabetics,
Anti-obesity, Marine sponge, Aka coralliphaga, Sarcotragus fasciculatusBackground
Glucosidase inhibitors are emerging as important thera-
peutic agents since they interfere with crucial metabolic
functions in biological systems, and have widespread ap-
plications in pharmacology and agriculture. They also
provide useful insights into the role of glucosidase in li-
ving systems and enzyme action mechanism. Their the-
rapeutic applications alone range from the treatment of
infections, to metabolic and genetic disorders like – viral
infections of HIV/Influenza, metastatic cancer, diabetes,
obesity and lysosomal storage diseases [1]. At present
nojirimycin and its derivatives are being extensively used
as β-glucosidase inhibitors. Some species of Streptomyces
and Bacillus produce antimicrobial compounds like vali-
damycin and nojirimycin, which showed β-glucosidase in-
hibition later on [2-4]. Yet the search for β-glucosidase* Correspondence: sony@immt.res.in
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reproduction in any medium, provided the orinhibitors in microorganisms is very much limited, though
natural sources like plant extracts, microalgae, cyanobac-
teria and mushrooms have been explored [5-8].
The natural compounds exhibiting β-glucosidase in-
hibition belong to a variety of chemical classes like di-
saccharides, iminosugars, carbasugars, thiosugars and
non-sugar derivatives [9]. There are naturally occurring
sugar mimics in the plant and microbial world which
have the potential to act as β-glucosidase inhibitors,
since they are structural analogues of natural sugar sub-
strates [10]. Beta-glucosidase inhibitors exhibit a range
of structure and functions in nature, so it is intriguing to
search for these inhibitors in natural resources, which
have the potential to produce different structures. Ma-
rine microflora is one such natural resource which re-
mains to be explored for the presence of β-glucosidase
inhibitors. Microbes living in the marine environment
survive under extreme conditions of temperature, pres-
sure and nutritional competition; and hence they possessLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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terrestrial counterparts. The inhibitors of β-glucosidases
are expected to be diverse in the marine environment
since this enzyme is widespread and diverse [11]. In the
past few decades, marine microbes from the sponges
and sediment have given several novel therapeutic mole-
cules [12]. However, except for a report by Imada and
Okami 1995 [13], on a deep-sea actinomycete isolate
producing β-glucosidase inhibitor, we did not find any
literature in this area. This prompted us to seek β-
glucosidase inhibitors in marine sponge and sediment as-
sociated bacteria.
When we investigated the microbial associates of sponges
and sediments using our new method of β-glucosidase
inhibition assay, we found β-glucosidase inhibitors in
several marine microbial extracts [14]. Many authors
have emphasized that phylogenetic diversity is the source
of varied biological activity [15-17]. Thus, the objective of
this study was to find the taxonomic groups of bacteria,
isolated from marine sponges and sediment samples, in-
volved in the inhibition activity. To the best of our know-
ledge, this report is the first to point out the phylogenetic
diversity of marine microbes producing β-glucosidase
inhibitors.
Results and discussion
Glucosidases catalyze the cleavage of glycosidic bonds
involving α- and β-linked glucose units or the bonds bet-
ween sugars and a non-carbohydrate aglycone moiety.
Beta-glucosidases play a crucial role in several biochemicalTable 1 Data on screening results




SD1 Sediment 27 11
SD2 Sediment 30 13
GD Sediment 53 3
Sponge Sarcotragus fasciculatus 41 6
Sponge Aka coralliphaga 30 8
Total 181 41
* Number in brackets are unidentified at species level.
^ The numbers exclude overlapping genus and species obtained in different samples.processes like degradation of polysaccharides, lysosomal
glycoconjugate catabolism, glycoprotein and glycolipid
processing. Glucosidase inhibitors have become the sub-
ject of intense scrutiny since the isolation of deoxynoji-
rimycin in 1966, because of their profound effect on
glycoprotein processing, oligosaccharide metabolism, cell-
cell and cell-virus recognition processes [18,19]. Our aim
was to find the diversity of marine bacteria producing
β-glucosidase inhibitors in response to the presence of this
enzyme in their environment, and we indeed found highly
diverse microbial population possessing the ability to pro-
duce these enzyme inhibitors.
Out of the 181 isolates tested 41 (22.7%) organisms
showed β-glucosidase inhibition potential; of these 41
isolates, 27 belonged to sediment samples, 6 and 8 res-
pectively from the sponge Sarcotragus fasciculatus and
Aka coralliphaga of Bay of Bengal. Table 1 presents
quantitative data on the number of samples screened,
beta-glucosidase inhibiting organisms and their diversity
at phyla level. Our results show that 22.7% of the mi-
croorganisms screened are able to inhibit β-glucosidase,
which further strengthens the belief that glucosidase in-
hibitors are widespread in the plant and microbial world
[10]. Twenty seven (24.5%) out of 110 isolates from sedi-
ment samples were positive for beta-glucosidase, 6 out
of the 41 (14.6%) isolates from the sponge Sarcotragus
fasciculatus and 8 out of 30 (26.6%) from the sponge
Aka coralliphaga produced the inhibitors. Since long,
the marine sponge associated microbes have been




No. of different phyla
obtained




9 (2) 5 Firmicutes – 10
Actinobacteria – 2
Proteobacteria – 1
2 (1) 3 Firmicutes – 1
Actinobacteria – 1
Proteobacteria – 1
3 (1) 3 Firmicutes – 5
Proteobacteria – 1




Table 2 β-Glucosidase inhibition activity and identity of the marine isolates
Sl. No. Strain β-Glucosidase
inhibition (in mm*)
Identity (%) Closest match GenBank accession
number
1 SD1-1 4 99.8 Stenotrophomonas rhizophila JQ359448
2 SD1-3 4 100 Arthrobacter koreensis JQ409500
3 SD1-6(1) 5 99.0 Advenella kashmirensis JQ359449
4 SD1-8 5 99.7 Microbacterium oleivorans JQ359450
5 SD1-13 4 100 Arthrobacter koreensis JQ409501
6 SD1-14(1) 6 99.8 Planomicrobium okeanokoites JQ409502
7 SD1-17 4 97.3 Dietzia maris JQ409503
8 SD1-18 4 96.0 Chryseomicrobium sp. JQ409504
9 SD1-20(1) 4 90.0 Sphingobacterium sp. JQ409505
10 SD1-23 4 97.3 Exiguobacterium marinum JQ409506
11 SD1-25 4 98.5 Stenotrophomonas rhizophila JQ409507
12 SD2-1 4 100 Bacillus flexus JQ409508
13 SD2-2(1) 5 99.5 Bacillus oceanisediminis JQ409509
14 SD2-2(2) 5 100 Bacillus siamensis JQ409510
15 SD2-3(2) 6 100 Bacillus flexus JQ409511
16 SD2-5 4 100 Bacillus sp. –
17 SD2-6(1) 5 100 Arthrobacter koreensis JQ409512
18 SD2-7(2) 5 100 Bacillus stratosphericus JQ409513
19 SD2-15(1) 4 91.0 Exiguobacterium sp. JQ409514
20 SD2-17 4 99.1 Bacillus oceanisediminis JQ409515
21 SD2-18 4 99.8 Microbacterium esteraromaticum JQ409516
22 SD2-20 4 98.7 Bacillus methylotrophicus JQ409517
23 SD2-22 5 99.8 Bacillus subtilis subsp. inaquosorum JQ409518
24 SD2-24 4 99.7 Psychrobacter maritimus JQ409519
25 GDN4 5 99.6 Vibrio communis JQ409520
26 GDB16 5 95 Bacillus sp. JQ409521
27 GDA11 4 99.6 Streptomyces coelicoflavus JQ409522
28 GPB8 4 99.7 Staphylococcus gallinarum JQ409523
29 GPB9 4 99.7 Bacillus subtilis subsp. spizizenii JQ409524
30 GPB10 4 96.0 Pseudochrobactrum sp. JQ409525
31 GPB13 4 100 Bacillus aryabhattai JQ409526
32 GPB20 4 99.6 Bacillus aryabhattai JQ409527
33 GPB21 4 100 Staphylococcus gallinarum JQ409528
34 SP2B3 6 97.8 Halomonas sulfidaeris JQ409529
35 SP2B5 4 99.4 Bacillus tequilensis JQ409530
36 SP2B6 6 95.5 Bacillus sp. --
37 SP2B9 6 99.7 Leucobacter chromiiresistens JQ409531
38 SP2B11 5 98.8 Planococcus rifitoensis JQ409532
39 SP2B12 5 99.5 Bacillus stratosphericus JQ409533
40 SP2B20 6 100 Bacillus amyloliquefaciens subsp. amyloliquefaciens JQ409534
41 SP2A6 4 97.6 Streptomyces rangoonensis JQ409535
* Standard deviation ± 0.5 mm.
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source of the inhibitor compound.
All the active isolates were identified by partial 16S
rDNA sequencing in the V1-V3 variable region and
confirmed by culture characterization (data not shown).
While Table 1 shows the quantitative data of the scree-
ning activity, Table 2 shows the qualitative data on the
activity and identity of the positive isolates. The distribu-
tion of active isolates among different bacterial phyla is
depicted in Figure 1. Based on the 16S rDNA sequence
data, a phylogenetic tree was drawn (Figure 2).
An explanation to the observation of a wide range of
microbial taxa involved in this activity could lie in the
competitiveness of the ecosystem. In the ocean ecosys-
tem, decomposable organic material is scarcely available
so most of the heterotrophic bacteria in the ecosystem
would secrete the glucosidase enzyme; and in order to
compete with others for the small amount of nutrition,
they would also secrete a variety of glucosidase inhibi-
tors. The role of organic carbon availability is evident in
the study by Liu et al. 2008, where the β-glucosidase ac-
tivity of mangrove sediments was compared with other
water bodies including deep sea. The activity was found
to be highest in the mangrove ecosystem due to the abun-
dant availability of decomposable organic matter [23].
An interesting observation from this study is that
very few Actinomycetes (21.9%), contrary to their popu-
lar characteristic of bioactivity, have shown glucosidase
inhibition as compared to Firmicutes bacteria (58.5%)
[15,16]. Observation of Table 2 shows glucosidase inhib-
ition by species belonging to diverse genera; however
only two species of Streptomyces were active. Six genera
of Firmicutes bacteria – Planomicrobium, Chryseomi-
crobium, Exiguobacterium, Bacillus, Staphylococcus and
Planococcus; and five genera of Actinobacteria – Leu-









Figure 1 Distribution of β-glucosidase inhibiting marine
isolates in different bacterial phyla showing Firmicutes making
up the major fraction followed by Actinobacteria, Proteobacteria
and Bacteroidetes. Within Proteobacteria, the γ-Proteobacteria
constitutes the major fraction.Dietzia, exhibited β-glucosidase inhibition. The bioactive
isolates from sediment samples belonged to four phyla,
whereas only three phyla were detected in the sponge
samples (Table 1).
According to Stein et al. 1984, deoxynojirimycin has
been isolated earlier from several species of Bacillus
(phylum Firmicutes) and Streptomyces (phylum Actino-
bacteria) [4]. Even in our study majority of the active
isolates belong to these phyla but, we report number of
genera from these phyla to produce such natural com-
pounds. Our finding is consistent with the general per-
ception that, Firmicutes and Actinobacteria are better
competitors in the natural environment since they are
prolific producers of antibiotics and enzyme inhibitors.
A significant number of isolates - 7 out of 41 (17.1%),
belong to phylum Proteobacteria with representatives of
all three classes α-, β- and γ-Proteobacteria. Species of
Bacillus and Streptomyces are already known for their
ability to produce diverse bioactive compounds; our fin-
ding is more important in the context of genera like
Staphylococcus, Stenotrophomonas, Pseudochrobactrum,
Advenella, Dietzia and Chryseomicrobium, which are
hitherto unknown as producers of antimicrobial and anti-
enzyme compounds. In fact, our study is the first to report
glucosidase inhibition in many genera of bacteria, which
have so far shown enzyme, cytotoxic, antimicrobial, anti-
oxidant, biosurfactant and metal resistance properties
only. Like, marine isolates of Planomicrobium, Planococ-
cus, Microbacterium, Arthrobacter, Halomonas and Psy-
chrobacter have shown weak cytotoxic activity earlier [24].
Enzymes like chitinase, xylanase, keratinase have been
reported from Planococcus rifitoensis [25], Arthrobacter
sp. [26] and Microbacterium sp. [27] respectively. Inte-
restingly, Sphingobacterium has previously shown thio-
glucosidase activity [28] and recently α-glucosidase has
also been reported from a strain of Halomonas [29]. In
fact, many Halomonas species are reported in litera-
ture with varied activity, for example, a marine derived
Halomonas strain produced certain antimicrobial and cy-
totoxic compounds with the addition of anthranilic acid in
the fermentation medium [30]. Our study is also the first
to report very strong glucosidase inhibition activity in
a chromium resistant species of Leucobacter from the
sponge Aka coralliphaga. A number of other members
from this genus have shown to have chromium tolerance
and recently a species of Leucobacter has been reported to
have potential biosurfactant activity [31,32].
Natural products from microbial associates of marine
sponges and sediments are attractive because of the me-
tabolic diversity they exhibit and scalability of the pro-
duction process using biotechnological methods. Hence,
the supply problem associated with marine invertebrates
and plankton can be overcome [33]. Although the role
of glucosidase inhibitors in marine sponge is not clear
Figure 2 Phylogenetic tree involving all the taxa showing beta-glucosidase inhibition. The analysis involved 117 nucleotide sequences. All
ambiguous positions were removed for each sequence pair after performing pairwise deletion. The evolutionary history was inferred using the
Neighbor-Joining method [20]. Bootstrap test was performed on the clusters in 1000 replicates [21]. The evolutionary distances were computed
using the p-distance method [22] and are in the units of the number of base differences per site. The optimal tree with the sum of branch
length = 2.39 is shown. The tree was drawn to scale in circular branch style, with branch lengths in the same units as those of the evolutionary
distances used to infer the phylogenetic tree. There were a total of 1580 positions in the final dataset.
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cellular inhibitors are released to prevent the other mi-
crobes from utilizing the carbohydrate carbon. We believe
our revelations form only the tip of an iceberg, and there
are many more cell factories hidden in the deep sea.Conclusion
This study throws light on the microbial taxa which are
hitherto not known for producing such compounds. Thus,
within the realm of possibility we may assume these mi-
croorganisms have a potential to produce new glucosidase
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hydrate metabolism and efficient utilization of carbon
sources determines the viability of microbes in any envi-
ronment. In order to survive in competitive environments
like the marine ecosystem, the microbial cells need to pro-
duce inhibitors against the glucosidases of other microbes.
Sparse information is available on the glucosidase inhi-
bition activity of the diverse microbial phyla found in the
depths of ocean for comparison of our results. Probably
the missing link between the phylogenetic diversity and
functional diversity can be established, if all these inhibi-
tors are structurally identified and their reaction mecha-
nisms established.
Methods
Bacterial strains and culture conditions
A total of 181 marine microorganisms isolated from ma-
rine sediment (110), sponge Sarcotragus fasciculatus (41)
and sponge Aka coralliphaga (30) were selected for this
study, out of a collection of marine cultures isolated
from the Bay of Bengal on the east coast of India. All the
organisms grew on Nutrient Agar (Hi Media, Mumbai)
media prepared in 50% aged natural seawater at 30°C
within 48–72 hrs.
Extraction of metabolites
The marine cultures were grown in 50 ml Nutrient Broth
prepared in 50% natural seawater and incubated at 30°C
in 200 rpm shaker for 48 hrs. The cell biomass was cen-
trifuged at 9000 rpm for 20 min, and the supernatant
containing the secondary metabolites was collected in a
250 ml flask; followed by mixing 10% diaion HP-20
(Sigma) and magnetic stirring for 30 min. The contents of
the flask were packed in a glass column, washed with
15 ml distilled water, and eluted with 20 ml methanol.
The methanol fractions were evaporated in a rotary evap-
orator (Heidolph, Germany) and dissolved in DMSO, to
make a final concentration of approx. 1 mg/ml and stored
at - 20°C.
Beta-glucosidase inhibition assay
The assay was performed as described by Pandey et al.
2013 [14]. Briefly, 10 ml enzyme agar solution was
prepared with 0.7% agar powder dissolved at 80-100°C in
0.1 M sodium acetate buffer, followed by the addition of
0.06% FeCl3 and 0.01 U/ml enzyme β-glucosidase added
at 60°C, and the solution was poured into petri plates.
Then 5 μl of the samples were inoculated on the surface
of the agar plate and incubated at room temperature for
15 min, followed by the addition of 0.2% esculin solution
and again incubated at room temperature for 30 min for
enzyme-substrate reaction. DMSO without extract was
used as negative control, and the positive control was
0.75 μg conduritol β-epoxide. The results were recordedby measuring the zone size. These experiments were re-
peated thrice with some extracts to check the reproduci-
bility of results.
Microbial identification
All the cultures which showed a positive zone of inhi-
bition were identified by morphological characterization
and 16S rRNA gene sequencing. DNA was isolated from
the pure cultures by the method described by Pitcher
et al., 1989 [34]. Purified genomic DNA was subjected
to 16S rRNA gene amplification using the universal pri-
mers 27F and 1492R in a thermal Cycler (Eppendorf ).
The PCR amplification was performed in 25 μl reaction
mixture containing 10 pmol of both the primers, 100–
150 ng DNA, 5 mM dNTPs, 1X Taq polymerase buffer
containing 15 mM MgCl2 and 0.5 μl of Taq DNA poly-
merase (5 U/μl, Fermentas). The PCR programme was
as follows: initial denaturation at 94°C for 5 min, 30 -
cycles of 94°C for 1 min, 50°C for 1 min, 72°C for 2 min
and final elongation at 72°C for 10 min. The PCR prod-
uct was separated on 1% agarose gel and the DNA frag-
ments were extracted using Gel Extraction kit (Qiagen)
as per the manufacturer’s instructions. The purified 16S
rDNA was sequenced at Merck Biosciences, Bangalore
and CSIR-IMMT in Beckman Coulter CEQ 8000 genetic
analysis system. The sequences thus obtained were
aligned with the GenBank sequences using BLAST pro-
gram in NCBI (http://blast.ncbi.nlm.nih.gov) and the
EzTaxon server 2.1 (http://147.47.212.35:8080/) [35], to
obtain the closest matching type strain sequences from
the database. The identity of the strain was established
based on the sequence identity and corresponding mor-
phological characters.
Phylogenetic analysis
The 16S rDNA sequences of the closest relatives of all
the marine cultures showing positive glucosidase inhibi-
tion were retrieved from EzTaxon, and multiple sequence
alignment was performed using Clustal_X program [36].
The evolutionary relatedness of all the strains was inferred
using the Neighbor-Joining method, distance calculated
using the p-distance method, followed by bootstrap test in
1000 replicates for each cluster and the phylogenetic tree
was drawn in MEGA5.0 program available at http://www.
megasoftware.net/ [37].
Competing interests
The authors declare no competing interests.
Authors’ contributions
SP contributed to the experimental design, data acquisition, troubleshooting,
analysis and interpretation of data, as well as drafting the manuscript. AS
conceived the work, collected samples, and advised on the manuscript. SSD,
DPD and LC helped in sample preparations and execution of work. All the
authors have read and approved the final manuscript.
Pandey et al. Microbial Cell Factories 2013, 12:35 Page 7 of 7
http://www.microbialcellfactories.com/content/12/1/35Acknowledgements
The authors are thankful to Council of Scientific and Industrial Research for
funding the work and Director CSIR-IMMT for the infrastructure support. We
gratefully acknowledge Dr. Tapan Chakrabarti, former Head and founder of
Microbial Type Culture Collection – an International Depository Authority,
Chandigarh, India, for critically examining the manuscript.
Received: 6 March 2013 Accepted: 14 April 2013
Published: 17 April 2013References
1. Asano N: Glycosidase inhibitors: updates and perspectives on practical
use. Glycobiology 2003, 13:93R–104R.
2. Zhu YP, Yin LJ, Cheng YQ, Yamaki K, Mori Y, Su YC, Li LT: Effects of sources
of carbon and nitrogen on production of α-glucosidase inhibitor by a
newly isolated strain of Bacillus subtilis B2. Food Chem 2008, 109:737–742.
3. Schmidt DD, Frommer W, Muller L, Truscheit E: Glucosidase inhibitors from
Bacilli. Naturwissenschaften 1979, 66:584–585.
4. Stein DC, Kopec LK, Yasbin RE, Young FE: Characterization of Bacillus
subtilis DSM704 and its production of 1-Deoxynojirimycin. Appl Environ
Microb 1984, 48:280–284.
5. Ramkumar KM, Thayumanavan B, Palvannan T, Rajaguru P: Inhibitory effect
of Gymnema Montanum leaves on α-glucosidase activity and α-amylase
activity and their relationship with polyphenolic content. Med Chem Res
2009. doi:10.1007/s00044-009-9241-5.
6. Kim JH, Ryu YB, Kang NS, Lee BW, Heo JS, Jeong IY, Park KH: Glycosidase
inhibitory Flavonoids from Sophora flavescens. Biol Pharm Bull 2006,
29:302–305.
7. Atsumi S, Umezawa K, Iinuma H, Naganawa H, Iitaka Y, Takeuchi T:
Production, isolation and structure determination of a novel
β-glucosiadse inhibitor cyclophellitol, from Phellinus sp. J Antibiot
1990, 43:49–53.
8. Cannell RJP, Kellam SJ, Owsianka AM, Walker JM: Microalgae and
cyanobacteria as a source of glycosidase inhibitors. J Gen Microbiol 1987,
133:1701–1705.
9. de Melo EB, Gomes AS, Carvalho I: α- and β-Glucosidase inhibitors: chemical
structure and biological activity. Tetrahedron 2006, 62:10277–10302.
10. Asano N, Nash RJ, Molyneux RJ, Fleet GWJ: Sugar-mimic glycosidase
inhibitors: natural occurrence, biological activity and prospects for
therapeutic application. Tetrahedron-Asymmetr 2000, 11:1645–1680.
11. Arrieta JM, Herndl GJ: Assessing the diversity of marine bacterial beta-
glucosidases by capillary electrophoresis Zymography. Appl Environ
Microb 2001, 67:4896–4900.
12. Zhang L, Rong A, Wang J, Sun N, Zhang S, Hu J, Kuai J: Exploring novel
bioactive compounds from marine microbes. Curr Opin Microbiol 2005,
8:276–281.
13. Imada C, Okami Y: Characteristics of marine actinomycete isolated from a
deep-sea sediment and production of β-glucosidase inhibitor. J Mar
Biotechnol 1995, 2:109–113.
14. Pandey S, Sree A, Dash SS, Sethi DP: A novel method for screening
beta-glucosidase inhibitors. BMC Microbiol 2013, 13:55. doi:10.1186/
1471-2180-13-55.
15. Lam KS: Discovery of novel metabolites from marine actinomycetes.
Curr Opin Microbiol 2006, 9:245–251.
16. Bull AT, Stach JE, Ward AC, Goodfellow M: Marine actinobacteria:
perspectives, challenges, future directions. Antonie Van Leeuwenhoek 2005,
87:65–79.
17. Haefner B: Drugs from the deep: marine natural products as drug
candidates. Drug Discov Today 2003, 8:536–544.
18. Stütz AE (Ed): Iminosugars as glycosidase inhibitors: Nojirimycin and beyond.
Weinheim: Wiley-VCH; 1999.
19. Lillelund VH, Jensen HH, Liang X, Bols M: Recent developments of
transition-state analogue glycosidase inhibitors of non-natural product
origin. Chem Rev 2002, 102:515–553.
20. Saitou N, Nei M: The neighbor-joining method: a new method for
reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406–425.
21. Felsenstein J: Confidence limits on phylogenies: an approach using the
bootstrap. Evolution 1985, 39:783–791.
22. Nei M, Kumar S: Molecular Evolution and Phylogenetics. New York: Oxford
University Press; 2000.23. Liu HJ, Tian Y, Zheng TL, Yan CL, Hong HS: Studies of glucosidase
activities from surface sediments in mangrove swamp. J Exp Mar Biol Ecol
2008, 367:111–117.
24. Zeng X, Xiao X, Li D, Gu Q, Wang F: Isolation identification and screening
of microorganisms for cytotoxic activities from deep sea sediments at
different pacific stations. World J Microb Biot 2010, 26:2141–2150.
25. Essghaier B, Rouaissi M, Boudabous A, Jijakli H, Sadfi-Zouaoui N: Production
and partial characterization of chitinase from a halotolerant Planococcus
rifitoensis strain M2-26. World J Microb Biot 2010, 26:977–984.
26. Murugan S, Arnold D, Pongiya UD, Narayanan PM: Production of Xylanase
from Arthrobacter sp. MTCC 6915 using saw dust as substrate under
solid state fermentation. Enzyme Research 2011:7. doi:10.4061/2011/696942.
Article ID 696942.
27. Riffel A, Brandelli A: Keratinolytic bacteria isolated from feather waste.
Braz J Microbiol 2006, 37:395–399.
28. Meulenbeld GH, Hartmans S: Thioglucosidase activity from
Sphingobacterium sp. strain OTG1. Appl Microbiol Biot 2001, 56:700–706.
29. Ojima T, Saburi W, Yamamoto T, Kudo T: Characterization of Halomonas
sp. Strain H11 α-Glucosidase activated by monovalent cations and its
application for efficient synthesis of α-D-Glucosylglycerol. Appl Environ
Microb 2012, 78:1836–1845.
30. Bitzer J, Grosse T, Wang L, Lang S, Beil W, Zeeck A: New
aminophenoxazinones from a marine Halomonas sp.: fermentation,
structure elucidation, and biological activity. J Antibiot 2006, 59:86–92.
31. Saimmai A, Sobhon V, Maneerat S: Production of biosurfactant from a
new and promising strain of Leucobacter komagatae 183. Ann Microbiol
2012, 62:392–402.
32. Halpern M, Shake’ d T, Pukall R, Schumann P: Leucobacter chironomi sp.
nov., a chromateresistant bacterium isolated from a chironomid egg
mass. Int J Syst Evol Micr 2009, 59:665–670.
33. Proksch P, Edrada RA, Ebel R: Drugs from the seas – current status and
microbiological implications. Appl Microbiol Biot 2002, 59:125–134.
34. Pitcher DJ, Saunders NA, Owen RJ: Rapid extraction of bacterial genomic
DNA with guanidium thiocyanate. Lett Appl Microbiol 1989, 8:151–156.
35. Chun J, Lee JH, Jung Y, Kim M, Kim S, Kim BK, Lim YW: EzTaxon: a web-based
tool for the identification of prokaryotes based on 16S ribosomal RNA
gene sequences. Int J Syst Evol Micr 2007, 57:2259–2261.
36. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG:
The CLUSTAL_X Windows interface: flexible strategies for multiple
sequence alignment aided by quality analysis tools. Nucleic Acids Res
1997, 25:4876–4882.
37. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5:
Molecular Evolutionary Genetics Analysis using Maximum Likelihood,
Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol
2011, 28:2731–2739.
doi:10.1186/1475-2859-12-35
Cite this article as: Pandey et al.: Diversity of marine bacteria producing
beta-glucosidase inhibitors. Microbial Cell Factories 2013 12:35.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
